As we celebrate International Women's Day, it is important to recognize the contributions of women in pharma research in APAC. These women have made remarkable contributions to the industry with their expertise, intelligence, and dedication. In this article, we highlight 15 leading women in pharma research in APAC and their outstanding contributions.

1. Dr. Hua Mu - As the Vice President and Head of Discovery Research at BeiGene, Dr. Mu leads the company's efforts in developing innovative cancer treatments. Her research has focused on developing new therapies that target genetic mutations in cancer cells.

2. Dr. Sunita Aggarwal - As the Vice President and Head of Biologics Research and Development at Sun Pharma, Dr. Aggarwal is responsible for overseeing the development of biosimilars and novel biologics. Her research has led to the development of new treatments for chronic diseases such as psoriasis, rheumatoid arthritis, and Crohn's disease.

3. Dr. Jenny Zheng - As the Executive Director of Translational Medicine at BeiGene, Dr. Zheng is responsible for the development of new therapies for cancer and other diseases. Her research has focused on developing treatments that target specific genetic mutations in cancer cells.

4. Dr. Winnie W. Y. Leung - As the Vice President of R&D and Chief Scientific Officer at Sanomics Ltd, Dr. Leung leads the company's efforts in developing personalized medicine for cancer patients. Her research has focused on identifying biomarkers that can be used to develop personalized cancer treatments.

5. Dr. Anjali Jain - As the Vice President of Medical Affairs at MSD India, Dr. Jain is responsible for overseeing the company's medical affairs activities in India. Her research has focused on developing new treatments for infectious diseases such as tuberculosis and HIV/AIDS.

6. Dr. Rashmi Hegde - As the Head of Global Research and Development at Lupin, Dr. Hegde is responsible for overseeing the company's R&D efforts in developing new treatments for a range of diseases. Her research has focused on developing treatments for cardiovascular diseases, diabetes, and respiratory diseases.

7. Dr. Jacqueline Tam - As the Head of Clinical Development at AstraZeneca Singapore, Dr. Tam is responsible for overseeing the company's clinical development activities in the Asia-Pacific region. Her research has focused on developing new treatments for cancer and other diseases.

8. Dr. Yvonne Lim - As the Head of Medical Affairs at Pfizer Singapore, Dr. Lim is responsible for overseeing the company's medical affairs activities in Singapore. Her research has focused on developing new treatments for infectious diseases such as pneumonia and meningitis.

9. Dr. Li Li - As the Executive Director and Head of the Cardiovascular and Metabolic Diseases Therapeutic Area at Covance, Dr. Li is responsible for overseeing the development of new treatments for cardiovascular and metabolic diseases. Her research has focused on developing treatments for diabetes, obesity, and cardiovascular diseases.

10. Dr. May Han - As the Head of Medical Affairs at Janssen Singapore, Dr. Han is responsible for overseeing the company's medical affairs activities in Singapore. Her research has focused on developing new treatments for infectious diseases such as HIV/AIDS and hepatitis.

11. Dr. Frances Cheng - As the Director of Oncology Research at Amgen, Dr. Cheng is responsible for overseeing the company's research efforts in developing new cancer treatments. Her research has focused on developing treatments that target specific genetic mutations in cancer cells.

12. Dr. Renu Goyal - As the Senior Director of Clinical Development at Gilead Sciences, Dr. Goyal is responsible for overseeing the company's clinical development activities in the Asia-Pacific region. Her research has focused on developing new treatments for viral infections such as hepatitis B and C, and HIV/AIDS.

13. Dr. Xun Wang - As the Director of Pharmacology at Merck, Dr. Wang is responsible for overseeing the company's pharmacology research efforts. Her research has focused on developing new treatments for cardiovascular diseases and cancer.

14. Dr. Yvonne Loh - As the Vice President of Global Medical Affairs at AbbVie, Dr. Loh is responsible for overseeing the company's medical affairs activities globally. Her research has focused on developing new treatments for autoimmune diseases such as rheumatoid arthritis and psoriasis.

15. Dr. Wanjun Chen - As the Executive Director and Head of Clinical Pharmacology at Pfizer, Dr. Chen is responsible for overseeing the company's clinical pharmacology research efforts. Her research has focused on developing new treatments for neurological disorders such as Alzheimer's disease and Parkinson's disease.

These 15 women are just a few of the many talented and dedicated women in pharma research in APAC. Their contributions have helped to advance the industry and improve the lives of patients around the world. On this International Women's Day, let us celebrate and honor their achievements, and continue to support and encourage women in pharma research to pursue their passions and make their mark in the industry.

These 15 women are the epitome of excellence, dedication, and innovation in pharma research in APAC. They have broken down barriers, shattered glass ceilings, and paved the way for future generations of women in the industry. On this International Women's Day, let us celebrate and recognize their significant contributions, and continue to support and empower women in pharma research to make a difference in the world.